Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAberd Asia Inc Regulatory News (AAIF)

Share Price Information for Aberd Asia Inc (AAIF)

Share Price is delayed by 15 minutes
Get Live Data
330.00    4.00 (1.23%)
Bid:
328.00
Ask:
334.00
Spread: 6.00 (1.829%)
Market Cap: £470.30m
AAIF Live PriceLast checked at - London Stock Exchange

Intraday Aberd Asia Inc Share Chart

First Interim Dividend

15 Apr 2026 07:00

RNS Number : 4638A
Aberdeen Asian Income Fund Limited
15 April 2026
 

Aberdeen Asian Income Fund Limited (the "Company")

Legal Entity Identifier (LEI): 549300U76MLZF5F8MN87

 

15 April 2026

 

Declaration of First Interim Dividend

 

 

Highlights

 

· Annualised dividend yield of 6.8%.

· First quarterly interim dividend of 4.47p per share.

· Share price total return of 33.4% for the 12 month period ended 31 March 2026.

 

The Board is pleased to declare a first quarterly interim dividend of 4.47p per share for the year ended 31 December 2026. Based on a share price of 262p on 31 March 2026, this equates to an annualised dividend yield of 6.8%.

 

The first interim dividend will be paid on 22 May 2026 to shareholders on the register at the close of business on 24 April 2026. The ex-dividend date is 23 April 2026.

 

Shareholders who hold their shares on the main register are reminded that the Company's Registrar, Computershare Investor Services PLC, operates a dividend re-investment plan ("DRIP"). This can be a good way of building up a shareholding in the Company over time, whereby quarterly dividends are reinvested automatically in new shares. The deadline for elections under the DRIP is 30 April 2026.

 

Shareholders who hold their shares through a stockbroker or online dealing platform should be able to request for their dividends to be re-invested in a similar way, by contacting their stockbroker or selecting this option through their online dealing account.

 

 

Note:

The Company's dividend policy is to set the dividend at 1.5625% per quarter of the Company's net asset value ("NAV"), equating to approximately 6.25% of NAV per annum. The dividend is calculated using the Company's NAV on the last business day of the preceding financial quarter (i.e. the end of March, June, September and December). The first quarterly interim dividend of 4.47p per share is based on 1.5625% of the Company's NAV of 286.12p per share as at 31 March 2026.

 

 

For further information, please contact:

 

Aberdeen (Investment Manager):

Ben Heatley, Head of Closed End Fund Sales

Ben.Heatley@aberdeenplc.com

 

Maria Allen, Client Director, Closed End Funds

Maria.Allen@aberdeenplc.com

 

Peel Hunt LLP (Corporate Broker):

Luke Simpson, Huw Jeremy (Investment Banking)

Alex Howe, Richard Harris (Sales)

020 7418 8900

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVIIMFTMTMBBIF
Date   Source Headline
28th Feb 20255:09 pmRNSTransaction in Own Shares
28th Feb 20251:00 pmRNSNet Asset Value(s)
27th Feb 20255:21 pmRNSTransaction in Own Shares
27th Feb 202511:47 amRNSNet Asset Value(s)
26th Feb 20255:10 pmRNSTransaction in Own Shares
26th Feb 202512:28 pmRNSNet Asset Value(s)
25th Feb 20255:25 pmRNSTransaction in Own Shares
25th Feb 202512:19 pmRNSNet Asset Value(s)
24th Feb 20255:13 pmRNSTransaction in Own Shares
24th Feb 20252:54 pmRNSGearing disclosure
24th Feb 202512:58 pmRNSNet Asset Value(s)
21st Feb 20255:07 pmRNSTransaction in Own Shares
21st Feb 202512:15 pmRNSNet Asset Value(s)
20th Feb 20255:10 pmRNSTransaction in Own Shares
20th Feb 202512:05 pmRNSNet Asset Value(s)
19th Feb 20255:10 pmRNSTransaction in Own Shares
19th Feb 202512:56 pmRNSNet Asset Value(s)
18th Feb 202512:44 pmRNSNet Asset Value(s)
17th Feb 20255:25 pmRNSTransaction in Own Shares
17th Feb 202512:59 pmRNSGearing disclosure
17th Feb 202512:46 pmRNSNet Asset Value(s)
14th Feb 202512:23 pmRNSNet Asset Value(s)
13th Feb 202512:14 pmRNSNet Asset Value(s)
13th Feb 202512:13 pmRNSPortfolio disclosure
12th Feb 202512:34 pmRNSNet Asset Value(s)
11th Feb 20255:20 pmRNSTransaction in Own Shares
11th Feb 202512:21 pmRNSNet Asset Value(s)
10th Feb 20255:21 pmRNSTransaction in Own Shares
10th Feb 20253:15 pmRNSGearing disclosure
10th Feb 20251:11 pmRNSNet Asset Value(s)
7th Feb 202511:49 amRNSNet Asset Value(s)
6th Feb 20255:13 pmRNSTransaction in Own Shares
6th Feb 20252:37 pmRNSMonth End Net Asset Value(s)
6th Feb 202512:55 pmRNSNet Asset Value(s)
5th Feb 20255:21 pmRNSTransaction in Own Shares
5th Feb 202511:55 amRNSNet Asset Value(s)
4th Feb 20255:26 pmRNSTransaction in Own Shares
4th Feb 202512:47 pmRNSNet Asset Value(s)
3rd Feb 20255:27 pmRNSTransaction in Own Shares
3rd Feb 20253:03 pmRNSGearing disclosure
3rd Feb 202511:34 amRNSCompliance with Market Abuse Regulation
3rd Feb 202510:50 amRNSTotal Voting Rights
31st Jan 20255:10 pmRNSTransaction in Own Shares
31st Jan 202512:19 pmRNSNet Asset Value(s)
30th Jan 20255:12 pmRNSTransaction in Own Shares
30th Jan 202512:57 pmRNSNet Asset Value(s)
29th Jan 20255:08 pmRNSTransaction in Own Shares
29th Jan 202512:41 pmRNSNet Asset Value(s)
28th Jan 20255:32 pmRNSTransaction in Own Shares
28th Jan 202512:22 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.